Browse the evidence

A very low carbohydrate-low protein (VLCLP) diet is the most effective macronutrient ratio for weight loss compared to a moderate fat-low protein (MFLP) control diet, achieving a mean weight loss of 4.10 kg.

If your primary goal is weight loss, a diet very low in carbohydrates (≤30% of calories) and low in protein (≤30% of calories) appears more effective than high-protein low-carb diets. This approach outperforms standard moderate-fat diets. Ensure you are overweight or obese, as results in normal-weight individuals are not well-established.

Low-carbohydrate diets can induce remission of type 2 diabetes, with clinical trials showing >50% remission rates in some studies.

If you have type 2 diabetes, a ketogenic diet (20-50g carbs/day) can potentially lead to remission. Work with your doctor to monitor blood sugar and adjust medications, as many patients reduce or stop medications within weeks.

Obesity causes secondary hormonal changes (elevated TSH, insulin/leptin resistance) that mimic hypothyroidism; weight loss alone can normalize these hormone levels without thyroid medication.

If you are obese and have slightly high TSH, it might be because of your weight, not a broken thyroid. Losing weight can often fix these hormone levels without medication. Ask your doctor if your thyroid issue is 'secondary' to obesity.

GLP-1 receptor agonists (e.g., tirzepatide) and bariatric surgery are highly effective for weight loss in patients with thyroid disease and should be considered when behavioral therapy fails, as they do not increase thyroid cancer risk in non-MTC patients.

If diet and exercise aren't enough, GLP-1 drugs or surgery are safe and effective options even if you have thyroid disease (unless you have a specific family history of thyroid cancer). These treatments cause significant weight loss (5-20%+) and improve cardiovascular health.

Integrating an online weight management program with population health management (PHM) support from nonclinical staff significantly improves patient engagement and weight loss outcomes compared to the online program alone.

If you are using a digital weight loss program, do not rely on it alone. Seek out programs that include human support, such as a coach or health manager, who can check in on your progress, answer questions, and provide accountability. This human element is critical for staying engaged and achieving better weight loss results.

Once-weekly semaglutide 2.4 mg significantly improves control of eating (specifically craving control and craving for savory foods) and sustains these improvements over 104 weeks, facilitating substantial weight loss in adults with overweight or obesity.

If you struggle with food cravings and hunger, especially when trying to lose weight, semaglutide 2.4 mg can help. It improves your ability to control what and how much you eat, particularly cravings for savory foods, and this effect lasts for at least two years. This helps you lose more weight and keep it off compared to lifestyle changes alone.

Semaglutide (GLP-1 receptor agonist) significantly reduces body weight, BMI, and waist circumference in overweight or obese adults, with or without type 2 diabetes, compared to placebo or other glucose-lowering medications.

If you are overweight or obese (BMI ≥24), semaglutide is a highly effective medical intervention for weight loss, working for both diabetic and non-diabetic individuals. It significantly reduces body weight, BMI, and waist circumference compared to placebo. While it can cause gastrointestinal side effects like nausea, serious adverse events are not more common than with a placebo. Be aware that stopping the medication may lead to weight regain, so long-term management and lifestyle changes are crucial.

Semaglutide increases the proportion of patients achieving significant weight loss thresholds (>5%, >10%, >15%, and >20%) compared to control groups.

Semaglutide significantly increases the likelihood of achieving major weight loss milestones (5%, 10%, 15%, 20%) compared to placebo or other treatments.

Cagrilintide-Semaglutide (CagriSema) produces superior weight loss and metabolic improvements compared to monotherapies and placebo in adults with overweight or obesity, with or without type 2 diabetes.

CagriSema is a potent, non-surgical weight loss option that significantly outperforms current GLP-1 monotherapies. It requires weekly (implied) injections and lifestyle changes. Expect transient GI side effects that usually subside. It is suitable for those with BMI ≥30 (or ≥27 with comorbidities), including those with T2D.

Continued structured support for weight loss maintenance in type 2 diabetes remission significantly reduces the incidence of moderate/major adverse cardiovascular events (MMACE) compared to standard care, with the benefit persisting over 5 years.

If you have achieved type 2 diabetes remission through weight loss, do not stop your efforts. The study shows that continuing structured support and maintaining your weight loss significantly lowers your risk of heart attacks and strokes over the next 5 years. Treat remission as a long-term commitment, not a one-time fix.

A ketogenic diet (defined as <50g carbohydrates/day) significantly improves body weight, waist circumference, HbA1c, triglycerides, and HDL levels in overweight patients with Type 2 Diabetes Mellitus compared to other dietary interventions.

For overweight individuals with Type 2 Diabetes, adopting a ketogenic diet (under 50g carbs daily) is a highly effective strategy for losing weight and improving blood sugar control. This approach also tends to improve heart health markers like HDL and triglycerides, addressing common concerns about high-fat diets. Consult a doctor to manage medications, as blood sugar levels may drop significantly.

Alternate day fasting (ADF) and modified ADF (MADF) are the most effective intermittent fasting regimens for weight loss, ranking higher than caloric energy restriction (CER) and time-restricted eating (TRE).

If your goal is maximum weight loss using intermittent fasting, Alternate Day Fasting (either zero-calorie or modified) appears to be the most effective strategy compared to Time-Restricted Eating or the 5:2 diet. However, adherence drops in longer studies, so consistency is key.

Liraglutide 3 mg daily induces significant weight loss in adults with obesity by slowing gastric emptying of solids and increasing satiation, with greater gastric emptying delay correlating with greater weight loss.

Take liraglutide 3 mg daily as prescribed, starting with a lower dose to minimize side effects. Expect some nausea initially, as this often signals the drug is working and may lead to greater weight loss. Combine with dietary counseling for best results. The medication works by slowing digestion and making you feel full sooner, helping you eat less.

Combined diet and exercise interventions produce greater reductions in liver enzymes (ALT, AST) and insulin resistance (HOMA-IR) than either diet or exercise alone in patients with NAFLD.

For NAFLD, doing just one thing (diet OR exercise) is less effective than doing both together. Aim for a caloric deficit (750-1000 kcal/day reduction) combined with at least 150 minutes of moderate-to-vigorous exercise per week. This combination is superior for lowering liver enzymes and improving insulin resistance compared to either intervention alone.

Exercise interventions significantly improve cardiorespiratory fitness and quality of life in NAFLD patients, even if weight loss is not statistically significant compared to control.

Even if you don't lose much weight, regular exercise (150+ mins/week) will improve your heart health, fitness, and quality of life. These benefits are distinct from weight loss and are valuable for NAFLD management.

Adhering to a vegan diet for at least 12 weeks significantly reduces body weight, BMI, HbA1c, total cholesterol, and LDL-C in individuals with overweight or type 2 diabetes compared to control diets.

If you have overweight or type 2 diabetes, switching to a vegan diet for at least 12 weeks can lead to meaningful weight loss and improved blood sugar and cholesterol levels. Most studies used low-fat vegan diets and provided B12 supplements. You do not necessarily need to count calories, as some studies were ad libitum, but energy intake was often lower. Ensure you get B12 supplementation.

The magnitude of weight loss and HbA1c reduction is greater when vegan diets are compared to habitual (passive) control diets rather than other active dietary interventions.

If you are comparing your vegan diet to your previous eating habits, you will likely see significant weight loss. If you are comparing it to another structured diet (like Mediterranean or ADA), the weight loss may be less pronounced, suggesting the vegan diet itself isn't inherently superior to all other diets, but rather superior to unstructured habitual eating.

Time-restricted feeding (TRF) with an 8-hour eating window (16:8) produces moderate weight loss in individuals with overweight or obesity, with effects potentially exceeding 5% of initial body weight when combined with caloric restriction.

If you have excess weight, try eating all your meals within an 8-hour window each day (e.g., 12 PM to 8 PM). You do not need to count calories if you are not used to it, but you must stop eating after your chosen end time. If you want faster results, combine this with a modest calorie reduction. Expect moderate weight loss, potentially over 5% of your body weight if you also restrict calories.

Time-Restricted Eating (TRE) results in greater reductions in body weight, fat mass, and fat-free mass compared to Continuous Energy Restriction (CER).

If you choose to use Time-Restricted Eating, you may see slightly better weight loss than with standard calorie counting. However, be aware that this also leads to greater loss of fat-free mass (muscle), which may not be desirable for everyone.

Intermittent fasting (IF) produces significantly greater weight loss than continuous calorie restriction (CCR) in overweight and obese adults, although both interventions result in similar improvements in BMI.

If your goal is maximum weight loss, intermittent fasting (like alternate-day fasting or restricted eating windows) may yield better results on the scale than simply eating less every day. However, if you are tracking BMI as your primary health metric, both methods work equally well. Choose the pattern you can sustain, as adherence is the biggest hurdle with fasting.

Alternate-Day Fasting (ADF) is the specific form of intermittent fasting that drives the superior weight loss results compared to Continuous Calorie Restriction, whereas 'normal' IF forms show no significant difference from CCR.

Not all fasting is created equal. If you want the maximum weight loss benefit, Alternate-Day Fasting (eating very little every other day) is the most effective strategy. However, if you prefer more flexible fasting windows (like skipping one meal a day), your weight loss will likely be similar to simply eating less every day, and you won't get the extra 'boost' that ADF provides.

Short-term multicomponent lifestyle interventions (6 months or less) combining nutrition and physical activity achieve statistically significant weight loss in adults with overweight or obesity compared to control groups.

If you have overweight or obesity, a structured program combining diet and exercise lasting 6 months or less can help you lose weight. You don't necessarily need a year-long commitment to see results. Look for programs that offer education, tracking tools, and support, as these multicomponent approaches are effective.

Tirzepatide produces the greatest weight loss and superior cardiometabolic improvements (blood pressure, triglycerides, glucose) among FDA/EMA-approved anti-obesity medications.

If you have obesity and comorbidities, Tirzepatide is currently the most effective FDA-approved medication for weight loss and improving metabolic markers like blood pressure and blood sugar. It outperforms Semaglutide in weight reduction magnitude.

Intermittent fasting for two consecutive days per week (IF2-P) produces significantly greater weight loss and waist circumference reduction than fasting for one day per week (IF1-P), despite both groups consuming matched total weekly energy intake and expenditure.

If you are overweight or obese, trying intermittent fasting for two consecutive days a week (like 26:2 or 60:168 patterns) may yield better weight loss results than fasting for just one day, even if you eat the same total amount of food over the week. Ensure your fasting days are nutrient-dense and low-sugar, and your feeding days include adequate protein (30-35% of calories) to preserve muscle mass.